Financial statements Lek-Pharma

Balance sheet of Lek-Pharma

Company age:
Age:
15 y. 4 m. 7 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of LEK-PHARMA

Year
2018
2019
2020
2021
2022
2022
2023
Total assets 4 894 017,72 5 824 515,00 7 197 181,92 6 726 799,90 7 556 685,00 7 148 209,00 7 904 934,00
A. Fixed assets 204 267,01 88 357,00 55 749,00 31 609,00 29 027,00 20 326,00 11 696,00
B. Current assets 4 689 750,71 5 736 158,00 7 141 432,92 6 695 190,90 7 527 658,00 7 127 883,00 7 893 238,00
C. Share capital contributions (basic funds) 0,00 - - - 0,00 0,00 0,00
D. Own shares (stocks) 0,00 - - - 0,00 0,00 0,00
Total liabilities 4 894 017,72 5 824 515,00 7 197 181,92 6 726 799,90 7 556 685,00 7 148 209,00 7 904 934,00
A. Equity 138 949,47 987 528,00 1 363 710,00 2 111 925,45 2 026 334,00 2 088 506,00 2 623 267,00
B. Liabilities and provisions for liabilities 4 755 068,25 4 836 987,00 5 833 471,92 4 614 874,45 5 530 351,00 5 059 703,00 5 281 667,00
I. Long-term liabilities 0,00 0,00 0,00 0,00 - - -
II. Short-term liabilities 4 755 068,25 4 836 987,00 4 569 962,92 4 148 041,17 5 530 351,00 5 059 703,00 5 281 667,00
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.